What Gartner’s data really says about selling medical devices in the age of AI
There’s a statistic making the rounds this spring that has a lot of sales leaders uneasy. Gartner found that 67% of B2B buyers would prefer a buying experience with no sales rep involved at all. Seventy percent want to go fully self-serve. If your entire go-to-market motion is built on reps getting prospects on the phone, that number reads like a countdown clock.
But there’s a second number in the same research, and it changes everything. Sixty-nine percent of those same buyers turn to a sales rep to validate what they’ve learned — including whatever AI told them. More than half say they’re actually more likely to get misleading information from generative AI than from a person. And when Gartner measured what genuinely moves a deal forward, human reps beat AI by wide margins: 32 points more likely to make a buyer feel confident in the decision, 39 points more likely to understand what the buyer actually needs.
So buyers want the rep gone — and they can’t finish the decision without one. That’s not a contradiction. It’s a sequence. And once you see the sequence, you see exactly what medical device selling is supposed to look like now.
Think about how you actually buy
Picture your own last serious purchase decision — something that mattered, that you were going to be accountable for. In the early phase, did you want a salesperson calling you? Almost certainly not. You wanted to learn. You wanted to pull information, compare, and form your own view, on your own schedule, without a rep in your ear steering you before you were ready.
And then something flips. At some point you convince yourself — this is probably the right choice. That’s the exact moment you want to talk to someone. Not to be sold. To validate. To confirm the thing you already believe is accurate, to ask the last two questions standing between you and a yes.
That’s the whole buying journey in miniature, and it’s true for the surgeon evaluating a new device, the supply-chain director, and the value-analysis committee member alike. Buyers do their homework alone. Then they invite a human in to check their work. The rep was never the problem. The timing was.
The motion that’s actually dying
Here’s the uncomfortable part for our industry. The thing Gartner’s 67% are rejecting isn’t the sales rep. It’s a specific, dated sales motion — the interruptive one. The “just checking in.” The “wanted to touch base.” The call that shows up on the buyer’s calendar for the rep’s benefit, not the buyer’s, in the middle of a phase where the buyer wanted to be left alone to learn.
That motion is dying because it was never actually serving the buyer — it was a way for reps to feel busy and for managers to see activity. And in a world where a buyer can pull most of the product information they need in ninety seconds, an interruptive call that offers no new information is worse than useless. It’s an annoyance that spends down trust the rep will want later, at the validation moment that actually counts.
Killing that motion doesn’t mean reps stop reaching out. It means what they reach out with has to change completely.
Put the information in their hands — and get out of the way
The reframe is simple to say and hard for legacy tooling to do: stop reaching out to ask for the buyer’s time, and start reaching out to give the buyer something worth having.
Instead of a rep calling to “check in,” imagine the rep sending a prospective client a clean, mobile-friendly piece of educational content about the product — something the buyer can open on their phone, explore at 10pm when it’s convenient for them, and put down when they’re done. No meeting to schedule. No small talk to endure. No day disrupted. Just the right information, in a format built for how people actually consume it, delivered the moment it’s relevant and not a second before the buyer wants it.
And it rarely comes down to a single piece. Device sales cycles can run for months and move through a whole cast of stakeholders, which is exactly why the real advantage is arming a rep with a library of this material — enough to support the entire journey. Three touches, four, five, each one a genuinely useful piece of validated information delivered at the right moment, and the buyer stays educated, informed, and engaged the whole way through without a single interruptive call. The rep keeps the deal moving without ever grinding for a meeting — and the buyer only reaches for the phone when they’re ready to validate and decide.
That’s not a softer version of selling. It’s a smarter one, and it maps precisely to how the decision gets made. Medical device buyers face a genuinely high bar — value-analysis committees want clinical evidence, economic rationale, and a clear-eyed view of fit before anything gets approved. Reps who can arm each stakeholder with exactly the right validated material, at the right time, in a form they’ll actually engage with, are doing the buyer’s homework with them instead of interrupting it.
And here’s the payoff, straight out of the Gartner data: if the information is good enough, the buyer will come to you. Give a buyer material strong enough to get them to “this is probably right,” and the very next thing they need is a person to validate it. You will not have to chase that conversation. You’ll have earned it. The 69% who want to confirm what they’ve learned will reach for the rep who taught them — not the one who kept interrupting them.
Great information doesn’t replace the rep. It summons one.
What this asks of a rep’s tools
If the motion changed this much, the toolbox built for the old motion is now working against you. The legacy stack — a CRM to log the check-in calls, a content portal nobody sends from, a file drive to email attachments out of — was designed to help reps manage activity and push. None of it was designed to help a rep put a genuinely great, on-brand, validated piece of information into a buyer’s hands in a way that respects the buyer’s time and timeline.
That’s the gap we built Nuvue to close. At its core it’s a presentation and information management platform, but what we’re really building is a sales system — one where reps don’t have to constantly pick up the phone or chase meetings to keep a deal alive. The philosophy underneath it is what matters: we put ourselves in the rep’s shoes. Rather than leave a rep with nothing to offer but “got a minute?”, we build them a whole library of educational, informational, validated content about their product that’s genuinely worth sending — deep enough to carry a buyer across a long sales cycle — and make it effortless to get that content into a prospect’s hands in a mobile-friendly format they’ll actually open. The rep’s outreach stops being an interruption and becomes a gift. The buyer explores when they’re ready. And when they’re ready to validate, the rep is the obvious person to call.
There’s a reason we obsess over getting reps productive fast, too. A rep who can’t quickly put the right information in front of the right stakeholder can’t earn that validation call — they fall back on the only motion they have left, which is to interrupt. Fluency isn’t a nicety here. It’s the difference between a rep buyers invite in and one they screen out.
The takeaway
The narrative that “AI is coming for the sales rep” gets medical device selling exactly backwards. AI didn’t kill the rep. It killed the interruption — the low-value, badly-timed outreach that buyers tolerated only because they had no better way to get information. Now they do. So the reps who win aren’t the ones who chase hardest. They’re the ones who show up with the best information, respect the buyer enough to let them explore it on their own terms, and become the trusted person the buyer chooses to call when it’s time to decide.
Give them the information. If it’s good enough, they’ll ask for the rep. Our whole job is to make sure it’s good enough — and that your reps are the ones holding it.